Longevity Biotech Company

Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures.

Technology: Metabolic Disorders
Headquarters: United States
Total Funding: $836.4K
Last Funding Type: Grant
Number Of Exists: Grant
Founded Date: 2010
Investors Number: 2
Industry: Energetic Process
Employee Number: 1-10
Estimated Revenue: Less than $1M
Investor Type: Company